KALY - Upcoming Trigger For This Hot Cannabis Stock Could Rocket PPS Up 1000%
January 24 2019 - 11:47AM
InvestorsHub NewsWire
New York, NY -- January 24, 2019 -- InvestorsHub NewsWire -- Kali,
Inc. (USOTC:
KALY) has proven to be a new hot cannabis stock over the past
two months and an upcoming trigger could rocket the current $0.01
PPS up 1000% to a $0.10 PPS.
The company entered the cannabis sector recently acquiring a
patented cannabis extraction technology. The technology has
been licensed by Puration, Inc. (USOTC: PURA) for the production of
CBT infused water sold into the sports nutrition market.
Together, KALY and PURA singed a deal to make a private labeled CBD
infused water for Generex Biotechnology (OTCQB: GNBT). KALY
also introduced its own CBD infused candies under the brand name
Hemp4mula. KALY’s greatest and yet unrecognized value is
derived from the company’s medical research surrounding the
extracts from the patented extraction process.
The acquisition of the patented extraction process and the
corresponding contract announcements saw the PPS rocket out of the
sub-penny range on trading volume that put it regularly in the top
25 most actively traded stocks on the OTCMarkets. The jump in
price and volume resulted in OTCMarkets flagging the stock for
potential promotion concerns. However, since the OTCMarkets
flag was posted, the company has updated its financial filings
bringing them current with OTCMarkets reporting standards for a
current information filer. The company has also launched a
new website consistent with its new cannabis business plan.
Its’ likely that OTCMarkets is reviewing KALY’s updated filings and
reviewing the increase in PPS and volume in reaction to the new
business plan and acquired assets and that the reviews will lead to
a removal of the currently posted flag for potential promotion
concerns.
The removal of the flag could be seen as a validation of the
company’s legitimate new cannabis business plan and assets and
could in turn be a trigger for another PPS run. When
considering KALY compared to a company such as Cannabis Science,
(USOTC: CBIS) with its negligible revenue, massive losses and
delinquent filings, but a $100 million market cap, it is not
unreasonable to think KALY’s PPS could run to $0.10 in response to
a clean bill of health, patented technology, revenue, and current
filings.
Learn more about the company at www.kali-extracts.com.
Disclaimer:
NextBigTicker.com (NBT)is a third party publisher and news
dissemination service provider. NBT is NOT affiliated in any
manner with any company mentioned herein. NBT is news dissemination
solutions provider and are NOT a registered
broker/dealer/analyst/adviser, holds no investment licenses and may
NOT sell, offer to sell or offer to buy any security. NBT's
market updates, news alerts and corporate profiles are NOT a
solicitation or recommendation to buy, sell or hold securities. The
material in this release is intended to be strictly informational
and is NEVER to be construed or interpreted as research material.
All readers are strongly urged to perform research and due
diligence on their own and consult a licensed financial
professional before considering any level of investing in
stocks. All material included herein is republished content
and details which were previously disseminated by the companies
mentioned in this release or opinion of the writer. NBT is not
liable for any investment decisions by its readers or subscribers.
Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. NBT has not been
compensated for this release and HOLDS NO SHARES OF ANY
COMPANY NAMED IN THIS RELEASE.
Disclaimer/Safe Harbor:
This news release contains forward-looking statements within the
meaning of the Securities Litigation Reform Act. The statements
reflect the Company's current views with respect to future events
that involve risks and uncertainties. Among others, these risks
include the expectation that any of the companies mentioned herein
will achieve significant sales, the failure to meet schedule or
performance requirements of the companies' contracts, the
companies' liquidity position, the companies' ability to obtain new
contracts, the emergence of competitors with greater financial
resources and the impact of competitive pricing. In the light of
these uncertainties, the forward-looking events referred to in this
release might not occur.
Source: www.nextbigticker.com